Displaying drugs 76 - 100 of 137 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB00105 |
Interferon Alfa-2b, Recombinant
99210-65-8 |
19271.0000 C860H1353N229O255S9 |
|
Antineoplastic Agents / Antiviral Agents / Immunomodulatory Agents | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma. |
| DB00011 |
Interferon alfa-n1
74899-72-2 |
19241.1000 C860H1353N227O255S9 |
|
Antiviral Agents / Immunomodulatory Agents | For treatment of venereal or genital warts caused by the Human Papiloma Virus |
| DB00018 | Interferon alfa-n3 |
|
Antineoplastic Agents / Antiviral Agents / Immunomodulatory Agents | For the intralesional treatment of refractory or recurring external condylomata acuminata. | |
| DB00069 |
Interferon alfacon-1
118390-30-0 |
19343.0000 C860H1353N227O255S9 |
|
Antineoplastic Agents / Antiviral Agents / Immunomodulatory Agents | For the treatment of hairy cell leukemia, malignant melanoma, and AIDS-related Kaposi's sarcoma |
| DB00060 |
Interferon beta-1a
145258-61-3 |
20027.0000 C908H1408N246O252S7 |
|
Antiviral Agents / Immunomodulatory Agents | For treatment of relapsing/remitting multiple sclerosis, also for condyloma acuminatum |
| DB00068 |
Interferon beta-1b
145155-23-3 |
20011.0000 C908H1408N246O253S6 |
|
Antiviral Agents / Immunomodulatory Agents | Interferon beta-1b is a drug used for the treatment of relapsing/remitting multiple sclerosis. It has been shown to slow the advance of the disease... |
| DB00033 |
Interferon gamma-1b
82115-62-6 |
17145.6000 C761H1206N214O225S6 |
|
Antiviral Agents / Immunomodulatory Agents | Interferon gamma-1b is used for the treatment of Chronic granulomatous disease and Osteopetrosis. |
| DB00028 |
Intravenous Immunoglobulin
9007-83-4 |
142682.3000 C6332H9826N1692O1980S42 |
|
Anti-Infectives / Immunomodulatory Agents | IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders. These indications includes idiopathic thromb... |
| DB00090 |
Laronidase
210589-09-6 |
69899.4000 C3160H4848N898O881S12 |
|
Enzyme Replacement Agents | For the treatment of mucopolysaccharidosis |
| DB00001 |
Lepirudin
120993-53-5 |
6963.4250 C287H440N80O110S6 |
|
Anticoagulants / Antithrombotic Agents / Fibrinolytic Agents | For the treatment of heparin-induced thrombocytopenia |
| DB00007 |
Leuprolide
53714-56-0 |
1209.3983 C59H84N16O12 |
|
Anti-Estrogen Agents / Antineoplastic Agents | For treatment of prostate cancer, endometriosis, uterine fibroids and premature puberty |
| DB06655 |
Liraglutide
204656-20-2 |
3751.2 Da C172H265N43O51 |
|
Glucagon-like peptide-1 [GLP-1] receptor agonist | For use in/treatment of diabetes mellitus type 2. |
| DB00044 |
Lutropin alfa
152923-57-4 |
23390.3000 C1014H1609N287O294S27 |
|
Fertility Agents | For treatment of female infertility |
| DB01277 |
Mecasermin
68562-41-4 |
7649.0000 C331H518N94O101S7 |
|
For the long-term treatment of growth failure in pediatric patients with Primary IGFD or with GH gene deletion who have developed neutralizing anti... | |
| DB00032 |
Menotropins
61489-71-2 |
23390.3000 C1014H1609N287O294S27 |
|
Fertility Agents | For the treatment of female infertility |
| DB00075 |
Muromonab
140608-64-6 |
146189.7000 C6460H9946N1720O2043S56 |
|
Immunomodulatory Agents / Immunosuppressive Agents | For treatment of organ transplant recipients, prevention of organ rejection |
| DB00108 |
Natalizumab
189261-10-7 |
|
Immunomodulatory Agents | For treatment of multiple sclerosis. | |
| DB04899 |
Nesiritide
124584-08-3 |
3464.0000 |
|
Cardiac drugs | For the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity. |
| DB00043 |
Omalizumab
242138-07-4 |
145058.2000 C6450H9916N1714O2023S38 |
|
Anti-Asthmatic Agents / Immunomodulatory Agents | For treatment of asthma caused by allergies |
| DB00038 |
Oprelvekin
145941-26-0 |
19047.2000 C854H1411N253O235S2 |
|
Coagulants / Thrombotics | Increases reduced platelet levels due to chemotherapy |
| DB00045 | OspA lipoprotein |
27743.1000 C1198H2012N322O422S2 |
|
Vaccines | For prophylactic treatment of Lyme Disease |
| DB00107 |
Oxytocin
50-56-6 |
1007.1870 C43H66N12O12S2 |
|
Anti-tocolytic Agents / Labor Induction Agents / Oxytocics | To assist in labor, elective labor induction, uterine contraction induction |
| DB00039 |
Palifermin
162394-19-6 |
16192.7000 C721H1142N202O204S9 |
|
Antimucositis Agents | For treatment of oral mucositis associated with chemotherapy and radiation therapy. |
| DB00110 |
Palivizumab
188039-54-5 |
|
Antiviral Agents | For prophylaxis of respiratory diseases casued by respiratory syncytial virus. | |
| DB00085 |
Pancrelipase
53608-75-6 |
131125.6000 C5850H8902N1606O1739S49 |
|
Enzyme Replacement Agents | For treatment of exocrine pancreatic insufficiency in cystic fibrosis (Ultresa™), chronic pancreatitis (Viokace™ in combination with a proton pump ... |
Displaying drugs 76 - 100 of 137 in total